Free Trial

Harbour Capital Advisors LLC Increases Stake in American Healthcare REIT, Inc. $AHR

American Healthcare REIT logo with Finance background

Key Points

  • Harbour Capital Advisors LLC has significantly increased its holdings in American Healthcare REIT, Inc. by 116.1%, acquiring an additional 38,745 shares during the second quarter, bringing its total to 72,120 shares valued at approximately $2.62 million.
  • Equities analysts have shown optimism for American Healthcare REIT, with target price increases from multiple firms, including JMP Securities raising their target from $40 to $45, and a consensus "Buy" rating with an average target of $42.80.
  • The company recently announced a quarterly dividend of $0.25 per share, with an annualized yield of 2.4%, despite a negative dividend payout ratio of -454.55%.
  • MarketBeat previews top five stocks to own in October.

Harbour Capital Advisors LLC lifted its position in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 116.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,120 shares of the company's stock after acquiring an additional 38,745 shares during the period. Harbour Capital Advisors LLC's holdings in American Healthcare REIT were worth $2,622,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the stock. Ameriprise Financial Inc. raised its stake in shares of American Healthcare REIT by 26.9% in the 4th quarter. Ameriprise Financial Inc. now owns 95,974 shares of the company's stock valued at $2,728,000 after purchasing an additional 20,366 shares during the period. ProShare Advisors LLC increased its holdings in American Healthcare REIT by 174.3% during the fourth quarter. ProShare Advisors LLC now owns 42,824 shares of the company's stock worth $1,217,000 after buying an additional 27,213 shares during the last quarter. Two Sigma Investments LP increased its stake in shares of American Healthcare REIT by 12.9% during the 4th quarter. Two Sigma Investments LP now owns 111,338 shares of the company's stock worth $3,164,000 after purchasing an additional 12,717 shares during the last quarter. Two Sigma Advisers LP grew its position in shares of American Healthcare REIT by 39.4% in the fourth quarter. Two Sigma Advisers LP now owns 13,100 shares of the company's stock valued at $372,000 after purchasing an additional 3,700 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in American Healthcare REIT by 115.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 767,365 shares of the company's stock valued at $21,809,000 after buying an additional 410,868 shares in the last quarter. 16.68% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at American Healthcare REIT

In other news, EVP Mark E. Foster sold 3,850 shares of American Healthcare REIT stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total value of $161,276.50. Following the completion of the transaction, the executive vice president directly owned 59,100 shares in the company, valued at approximately $2,475,699. The trade was a 6.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CIO Stefan K.L. Oh sold 3,860 shares of the business's stock in a transaction that occurred on Monday, June 30th. The shares were sold at an average price of $36.10, for a total transaction of $139,346.00. Following the transaction, the executive directly owned 95,671 shares of the company's stock, valued at approximately $3,453,723.10. This represents a 3.88% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.92% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on AHR shares. Scotiabank reiterated an "outperform" rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. Baird R W upgraded shares of American Healthcare REIT to a "strong-buy" rating in a research report on Thursday, July 17th. KeyCorp raised their price target on shares of American Healthcare REIT from $34.00 to $40.00 and gave the company an "overweight" rating in a research note on Wednesday, June 11th. UBS Group started coverage on shares of American Healthcare REIT in a research report on Friday. They issued a "buy" rating and a $51.00 target price on the stock. Finally, Morgan Stanley restated an "overweight" rating on shares of American Healthcare REIT in a research report on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating and eleven have assigned a Buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $42.80.

Get Our Latest Stock Report on American Healthcare REIT

American Healthcare REIT Stock Down 0.2%

AHR stock traded down $0.08 during trading on Monday, reaching $42.14. 1,167,502 shares of the stock were exchanged, compared to its average volume of 1,633,315. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.41. American Healthcare REIT, Inc. has a twelve month low of $23.66 and a twelve month high of $43.52. The firm's 50 day moving average is $40.67 and its 200 day moving average is $35.60. The firm has a market cap of $7.10 billion, a P/E ratio of -191.55, a price-to-earnings-growth ratio of 2.17 and a beta of 1.09.

American Healthcare REIT (NYSE:AHR - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.02. The business had revenue of $542.50 million during the quarter, compared to analyst estimates of $539.49 million. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.American Healthcare REIT's quarterly revenue was up 7.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.33 EPS. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. As a group, research analysts forecast that American Healthcare REIT, Inc. will post 1.41 EPS for the current year.

American Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 17th. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $1.00 annualized dividend and a dividend yield of 2.4%. American Healthcare REIT's dividend payout ratio (DPR) is currently -454.55%.

American Healthcare REIT Profile

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Featured Stories

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Should You Invest $1,000 in American Healthcare REIT Right Now?

Before you consider American Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.

While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.